Genome-scale meta-analysis of breast cancer datasets identifies promising targets for drug development

BACKGROUND: Because of the highly heterogeneous nature of breast cancer, each subtype differs in response to several treatment regimens. This has limited the therapeutic options for metastatic breast cancer disease requiring exploration of diverse therapeutic models to target tumor specific biomarke...

Descripción completa

Detalles Bibliográficos
Autores principales: Altaf, Reem, Nadeem, Humaira, Babar, Mustafeez Mujtaba, Ilyas, Umair, Muhammad, Syed Aun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885587/
https://www.ncbi.nlm.nih.gov/pubmed/33593445
http://dx.doi.org/10.1186/s40709-021-00136-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885587/
https://www.ncbi.nlm.nih.gov/pubmed/33593445
http://dx.doi.org/10.1186/s40709-021-00136-7

Ejemplares similares